| Category : |
Intermediates/Pharmaceutical intermediates |
 |
| CAS NO : |
89-25-8 |
| EC NO : |
201-891-0 |
| MF : |
C10H10N2O |
| MW : |
174.1992 |
| Specification : |
89-25-8 |
| Packing : |
25kg/Barrel |
| Product description : |
Synonyms:3-Methyl-1-phenyl-2-pyrazolin-5-one;1-Phenyl-3-methyl-5-pyrazolone;2,4-Dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one; C.I. Developer 1,
Molecular Formula：C10H10N2O,
Molecular Weight：174.20,
Quality Standard: Enterprise standard,
Appearance：A white or almost white crystalline powder,
Assay：NLT99.0%, |
| Uses : |
the raw material of the medicine which could improve the symptom neurosis/capacity of normal life activity/body dysfunction resulted from acute cerebral infarction. |
| Synonyms : |
PMP;Edaravone;5-Methyl-2-phenyl-1,2-dihydropyrazol-3-one;2,4-dihydro-5-methyl-2-phenyl-3h-pyrazol-3-one;C.I. Developer 1;MCI-186;1-Phenyl-3-Methyl-5-Pyrazole;1,3,5-PMP;1-Phenyl-3-Methyl-5-Pyrazolone;1-Phenyl-3-Methyl-5-Prazalone;3-Methyl-1-phenyl-5-pyrazolone;5-Pyrazolone-3-Methyl-1-Phenyl; |
| Molecular Structure : |
 |